Lasse Skibsbye

Lasse Skibsbye is a highly experienced professional in the field of pharmacology and toxicology, currently serving as a Member of the Board of Directors and Principal Scientist at H. Lundbeck A/S since May 2016. Lasse Skibsbye has held roles such as Primary Safety Pharmacologist and Senior Scientist within the department of Exploratory Toxicology. In addition to current positions with Danmarks Farmaceutiske Selskab and Hjerteforeningen, Lasse Skibsbye has a strong academic background, including a PhD from the University of Copenhagen focused on cardiovascular research. Lasse Skibsbye's professional journey includes founding Futurepharma ApS and significant research contributions, including postdoctoral studies in cardiac physiology and the development of safety pharmacology. Lasse Skibsbye is also a Board Member of the Safety Pharmacology Society and has been involved with the Faculty of Health and Medical Sciences at UCPH as a researcher and lecturer.